Font Size: a A A

The Study Of Vitro Effects And The Mechanism Of Thalidomide On Prostate Cancer Cell Line PC-3

Posted on:2013-02-17Degree:MasterType:Thesis
Country:ChinaCandidate:X H CuiFull Text:PDF
GTID:2234330362468885Subject:Surgery
Abstract/Summary:PDF Full Text Request
Objective: This experiment aimed to evaluate the effect of Thalidomide onproliferation and apoptosis and the expression of hypoxia inducible factor-1α(HIF-1α)、 vascular endothelial growth factor(VEGF)、Bcl-2and Bax proteins inprostate cancer cell line PC-3in vitro,to further investigate possible mechanism of itsrole as angiogenesis inhibitor and activity of anti-tumor on human prostate cancer cellline PC-3in vitro.Methods: l.Human prostate cancer cell line PC-3was incubated in culture medium invitro,using cell counting kit-8assay to detect the growth rate among differentthalidomide concentration groups(25、50、100μg/m1)and different time groups(24、48、72h). Apoptosis were examined with flow cytometry.2.According to the resultof CCK-8,establishing control and experimental group,extracting total RNA of eachgroup, assessing the integrality and content of RNA, the level of HIF-1α、VEGFmRNA expression was examined by semiquantitative RT-PCR technique in thePC-3cells treated before and after with thalidomide.3. The expression of HIF-1α、VEGF、Bcl-2and Bax protein in PC-3cells treated by Thalidomide was detected byWestern blot.Results:1. CCK-8assay results:Within the concentration of (10-100) μg/ml,thalidomide can obviously inhibit proliferation of PC-3in vitro.The inhibition ratiowas stepping up as the concentration increasing,and the highest inhibition ratio wasin the group with the concentration of l00μg/m1and72h.There was statisticalsignificance of inhibition ratio in different concentration groups of PC-3cells afterbeing treated thalidomide(P<0.05).The outcome of FCM indicated that after beingtreated with25、50、100μg/m1thalidomide for48h, the apoptotic percentage was16.32%、32.18%、42.68%.seperately,and there was statistically significant differencebetween control group and every treatment group(P <0.05).2.RT-PCR detection results:There was different depression of the HIF-1α、VEGF mRNA expression indifferent concentration groups of PC-3cells after being treatedthalidomide.Thalidomide obviously repressed the HIF-1α、VEGF mRNA expressionin PC-3at l00μg/m1after treating24h,and there was statistical significance betweenbefore and after treatment(P <0.05).3. The result of the Western blot showed that aftertreatment with different concentration of thalidomide for24h, the levels of Bcl-2、HIF-1α and VEGF proteins expression were down—regulated in aconcentration—dependent manner,and Bax was up-regulated.Conclusion:1.We comfirmed that thalidomide had the capability of inhibiting theproliferation of PC-3cells in vitro by a dose and time-dependent manner.2.Weconfirmed that thalidomide induced apoptosis in PC-3cells,which may mediated byBcl-2and Bax.expressing the inducement apoptoticis is one of the mechanisms of itsanti-tumor.3.Within a certain drug concentration.thalidomide can inhibit the mRNAand protein expression of HIF-1α and VEGF in PC-3cells.4.Thalidomide may beeffective in HIF-1α and VEGF this two valid targets in PC-3cells, inhibition ofangiogenesis of prostate cancer, leading to inhibition of prostate cancer growth andmetastasis.
Keywords/Search Tags:thalidomide, prostate cancer, cell apoptosis, hypoxia-induciblefactor-1α, vascular endothelial growth factor
PDF Full Text Request
Related items